Lyell Immunopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
CEOLynn Seely
CEOLynn Seely
Employees300
Employees300
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees300
Employees300
LYEL Key Statistics
Market cap557.23M
Market cap557.23M
Price-Earnings ratio-1.05
Price-Earnings ratio-1.05
Dividend yield—
Dividend yield—
Average volume113.37K
Average volume113.37K
High today$27.89
High today$27.89
Low today$24.22
Low today$24.22
Open price$24.51
Open price$24.51
Volume39.39K
Volume39.39K
52 Week high$45.00
52 Week high$45.00
52 Week low$7.65
52 Week low$7.65
Stock Snapshot
As of today, Lyell Immunopharma(LYEL) shares are valued at $26.23. The company's market cap stands at 557.23M, with a P/E ratio of -1.05.
On 2026-01-22, Lyell Immunopharma(LYEL) stock traded between a low of $24.22 and a high of $27.89. Shares are currently priced at $26.23, which is +8.3% above the low and -6.0% below the high.
Lyell Immunopharma(LYEL) shares are trading with a volume of 39.39K, against a daily average of 113.37K.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $45.00 and a 52-week low of $7.65.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $45.00 and a 52-week low of $7.65.
People also own
Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.